Literature DB >> 9609537

The effect of HFE mutations on serum ferritin and transferrin saturation in the Jersey population.

A T Merryweather-Clarke1, M Worwood, L Parkinson, C Mattock, J J Pointon, J D Shearman, K J Robson.   

Abstract

High frequencies of the haemochromatosis-related HFE C282Y mutation have been reported in North European populations, in which a high proportion of patients with the disease are homozygotes. However, the degree of penetrance of this genotype is unknown. We determined the HFE C282Y and H63D genotypes of 411 consenting volunteer blood donors on Jersey, and the serum ferritin and transferrin saturation levels of 204 of these volunteers. The C282Y allele frequency was found to be 8.3% in 822 chromosomes, indicating a homozygote frequency of 1/145. Consistent with this, four C282Y homozygotes were detected in 411 volunteers. As there are only 18 patients presently receiving treatment for haemochromatosis on Jersey, out of a total population of about 85000, there is a large discrepancy between the number of haemochromatosis patients and the number of C282Y homozygotes in this population. In a preliminary study of 204 consenting volunteers we found a correlation between transferrin saturation and HFE H63D/ C282Y genotype (P=0.017) and between serum ferritin and genotype (P = 0.056). We also observed elevated values of transferrin saturation in the two C282Y homozygotes assayed. These results suggest that a large proportion of the many undetected C282Y homozygotes on Jersey and in similar populations could be in the preclinical stages of haemochromatosis, and warrant investigation. However, there may be a wide variation in the expression of the condition, and a more extensive study of the level of disease penetrance encompassing a large number of hitherto undetected C282Y homozygotes is therefore imperative.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9609537     DOI: 10.1046/j.1365-2141.1998.00736.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  14 in total

1.  Heteroduplex analysis for the three common HFE variants: methodology, reliability and analysis of over 5000 requests for testing.

Authors:  Jeanne Kingston; Derrick Bowen; Marion Sweeney; Susan Lawless; Helen Jackson; Mark Worwood
Journal:  J Clin Pathol       Date:  2006-11-01       Impact factor: 3.411

2.  [Genetics and quaternary prevention. The example of haemochromatosis].

Authors:  J Gérvas; M Pérez Fernández
Journal:  Aten Primaria       Date:  2003       Impact factor: 1.137

3.  Iron genes, iron load and risk of Alzheimer's disease.

Authors:  D J Lehmann; M Worwood; R Ellis; V L J Wimhurst; A T Merryweather-Clarke; D R Warden; A D Smith; K J H Robson
Journal:  J Med Genet       Date:  2006-10       Impact factor: 6.318

Review 4.  Population screening for hemochromatosis: has the time finally come?

Authors:  J C Barton; R T Acton
Journal:  Curr Gastroenterol Rep       Date:  2000-02

5.  Incidence of liver disease in people with HFE mutations.

Authors:  G Willis; J Z Wimperis; R Lonsdale; I W Fellows; M A Watson; L M Skipper; B A Jennings
Journal:  Gut       Date:  2000-03       Impact factor: 23.059

Review 6.  Factors influencing disease phenotype and penetrance in HFE haemochromatosis.

Authors:  J Rochette; G Le Gac; K Lassoued; C Férec; K J H Robson
Journal:  Hum Genet       Date:  2010-07-06       Impact factor: 4.132

7.  The 16189 variant of mitochondrial DNA occurs more frequently in C282Y homozygotes with haemochromatosis than those without iron loading.

Authors:  K J Livesey; V L C Wimhurst; K Carter; M Worwood; E Cadet; J Rochette; A G Roberts; J J Pointon; A T Merryweather-Clarke; M L Bassett; A-M Jouanolle; A Mosser; V David; J Poulton; K J H Robson
Journal:  J Med Genet       Date:  2004-01       Impact factor: 6.318

Review 8.  Recent advances in understanding haemochromatosis: a transition state.

Authors:  K J H Robson; A T Merryweather-Clarke; E Cadet; V Viprakasit; M G Zaahl; J J Pointon; D J Weatherall; J Rochette
Journal:  J Med Genet       Date:  2004-10       Impact factor: 6.318

9.  Synergy between the C2 allele of transferrin and the C282Y allele of the haemochromatosis gene (HFE) as risk factors for developing Alzheimer's disease.

Authors:  K J H Robson; D J Lehmann; V L C Wimhurst; K J Livesey; M Combrinck; A T Merryweather-Clarke; D R Warden; A D Smith
Journal:  J Med Genet       Date:  2004-04       Impact factor: 6.318

10.  Frequencies of the hereditary hemochromatosis allele in different populations. Comparison of previous phenotypic methods and novel genotypic methods.

Authors:  Nils Milman; Palle Pedersen; Torkil á Steig; Gitte Vedel Melsen
Journal:  Int J Hematol       Date:  2003-01       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.